Harm, hype and evidence: ELSI research and policy guidance

Genome Medicine

Volumn 5, Issue 3, 2013, Pages

  Caulfield, Timothy ^a   Chandrasekharan, Subhashini ^b   Joly, Yann ^c   Cook Deegan, Robert ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHICS; GENETIC RISK; GENETIC SCREENING; GENOMICS; HUMAN; LEGAL ASPECT; MEDICAL RESEARCH; PATENT; POLICY; PRIORITY JOURNAL;

EID: 84874771931     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm425     Document Type: Article

References (53)

1. Skirton H, Goldsmith L, Jackson L, O'Connor A. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet 2012, 82:210-218. 10.1111/j.1399-0004.2012.01863.x, 22372614.
2. Genetic Information Nondiscrimination Act. 2008, Pub. L. No. 110-233, 122 Stat. 881.
3. UNESCO Universal Declaration on the Human Genome and Human Rights 1997, UNESCO, UNESCO., http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/human-genome-and-human-rights/
4. Eisenberg R. Technology policy perspective on the NIH gene patenting controversy. U Pitt L Rev 1993, 55:633-652.
5. Cook-Deegan R, Heaney C. Patents in genomics and human genetics. Annu Rev Genomics Hum Genet 2010, 11:383-425. 10.1146/annurev-genom-082509-141811, 2935940, 20590431.
6. Merz JF, Kriss AG, Leonard DG, Cho MK. Diagnostic testing fails the test. Nature 2002, 415:577-579. 10.1038/415577a, 2220021, 11832913.
7. Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF. Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003, 5:3-8. 10.1016/S1525-1578(10)60444-8, 1907368, 12552073.
8. Cook-Deegan R, Chandrasekharan S, Angrist M. The dangers of diagnostic monopolies. Nature 2009, 458:405-406. 10.1038/458405a, 2702156, 19325608.
9. Carbone J, Gold ER, Sampat B, Chandrasekharan S, Knowles L, Angrist M, Cook-Deegan R. DNA patents and diagnostics: not a pretty picture. Nat Biotechnol 2010, 28:784-791. 10.1038/nbt0810-784, 3026778, 20697400.
10. Gaisser S, Hopkins MM, Liddell K, Zika E, Ibarreta D. The phantom menace of gene patents. Nature 2009, 458:407-408. 10.1038/458407a, 19325609.
11. Hawkins N. The impact of human gene patents on genetic testing in the United Kingdom. Genet Med 2011, 13:320-324. 10.1097/GIM.0b013e3181fc50bc, 3319650, 21150786.
12. Chandrasekharan S, Cook-Deegan R. Gene patents and personalized medicine - what lies ahead?. Genome Med 2009, 1:92. 10.1186/gm92, 2768999, 19804612.
13. Kepler TB, Crossman C, Cook-Deegan R. Metastasizing patent claims on BRCA1. Genomics 2010, 95:312-314. 10.1016/j.ygeno.2010.03.003, 2857658, 20226239.
14. Holman CM. Debunking the myth that whole-genome sequencing infringes thousands of gene patents. Nat Biotechnol 2012, 30:240-244. 10.1038/nbt.2146, 22398617.
15. Association for Molecular Pathology et al. v. United States Patent and Trademark Office et al. USDC SDNY 09 Civ 4515 2010,
16. Caulfield T, Bubela T, Murdoch CJ. Myriad and the mass media: the covering of a gene patent controversy. Genet Med 2007, 9:850-855. 10.1097/GIM.0b013e31815bf965, 18091435.
17. Caulfield T, Cook-Deegan RM, Kieff FS, Walsh JP. Evidence and anecdotes: an analysis of human gene patenting controversies. Nat Biotechnol 2006, 24:1091-1094. 10.1038/nbt0906-1091, 2701726, 16964215.
18. Caulfield T. Direct-to-consumer testing: if consumers are not anxious, why are policymakers?. Hum Genet 2011, 130:23-25. 10.1007/s00439-011-0987-8, 21479954.
19. Secretary's Advisory Committee on Genetic Testing Enhancing the Oversight of Genetic Tests: Recommendations of the SACGT. Bethesda: National Institutes of Health 2000, Secretary's Advisory Committee on Genetic Testing., http://oba.od.nih.gov/oba/sacgt/reports/oversight_report.pdf
20. The Canadian College of Medical Geneticists Ethics and Policy Committee CCMG Statement on Direct-to-Consumer Genetic Testing. 2011, The Canadian College of Medical Geneticists Ethics and Policy Committee., http://www.ccmg-ccgm.org/documents/Policies Reports and Position Statements/Position Statements/PosStmt_EPP_DTC_FINAL_20Jan2011.pdf
21. James KM, Cowl CT, Tilburt JC, Sinicrope PS, Robinson ME, Frimannsdottir KR, Tiedje K, Koenig BA. Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc 2011, 86:933-940. 10.4065/mcp.2011.0190, 3184022, 21964170.
22. Collins RE, Wright AJ, Marteau TM. Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review. Genet Med 2011, 13:273-277. 10.1097/GIM.0b013e3181f710ca, 20921892.
23. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011, 364:524-534. 10.1056/NEJMoa1011893, 21226570.
24. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, Attwood S, Hollands GJ. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 2010, CD007275.
25. Reid RJ, McBride CM, Alford SH, Price C, Baxevanis AD, Brody LC, Larson EB. Association between health-service use and multiplex genetic testing. Genet Med 2012, 14:852-859. 10.1038/gim.2012.52, 22595941.
26. Borry P, van Hellemondt RE, Sprumont D, Jales CF, Rial-Sebbag E, Spranger TM, Curren L, Kaye J, Nys H, Howard H. Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 2012, 20:715-721. 10.1038/ejhg.2011.278, 22274578.
27. Lemmens T. Selective justice, genetic discrimination, and insurance: should we single out genes in our laws?. McGill Law J 2000, 45:347-412.
28. Martin DK, Greenwood HL, Nisker J. Public perceptions of ethical issues regarding adult predictive genetic testing. Health Care Anal 2010, 18:103-112. 10.1007/s10728-009-0113-4, 19288201.
29. Joly Y, Braker M, Le Huynh M. Genetic discrimination in private insurance: global perspectives. New Genet Soc 2010, 29:351-368.
30. Rosthstein MA, Joly Y. Genetic information and insurance underwriting: contemporary issues and approaches in the global economy insurance. Property and Privacy, Handbook of Genetics and Society: Mapping the New Genomic Era 2008, 127-144. New York: Routledge, Atkinson P, Glasner P, Lock M.
31. Otlowski M, Taylor S, Bombard Y. Genetic discrimination: international perspectives. Annu Rev Genomics Hum Genet 2012, 13:433-454. 10.1146/annurev-genom-090711-163800, 22607273.
32. Health Insurance Portability and Accountability Act. 45 CFR §§ 160.103, 164.501.
33. Patient Protection and Affordable Care Act. Pub. L. No. 111-148, 124 Stat. 119 (2010), § 2705.
34. Greely HT. Banning genetic discrimination. N Engl J Med 2005, 353:865-867. 10.1056/NEJMp058116, 16135828.
35. Joly Y, Ngueng Feze I. Genetic discrimination life insurance and evidence: a comprehensive review of 28 empirical studies. BMC Med 2013, 11:25. 10.1186/1741-7015-11-25, 23369270.
36. Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS, . I-RESPOND-HD Investigators of the Huntington Study Group Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1081-1093. 3593716, 20468061, I-RESPOND-HD Investigators of the Huntington Study Group.
37. Hall WD, Mathews R, Morley KI. Being more realistic about the public health impact of genomic medicine. PLoS Med 2010, 7:e1000347. 10.1371/journal.pmed.1000347, 2953533, 20967240.
38. Evans JP, Meslin EM, Marteau TM, Caulfield T. Genomics. Deflating the genomic bubble. Science 2011, 331:861-862. 10.1126/science.1198039, 21330519.
39. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. The predictive capacity of personal genome sequencing. Sci Transl Med 2012, 4:133ra58. 10.1126/scitranslmed.3003380, 22472521.
40. Caulfield T, Condit C. Science and the sources of hype. Public Health Genomics 2012, 15:209-217. 10.1159/000336533, 22488464.
41. Jones M. Beyond GINA, states build patchwork of protections. GenomeWeb Daily News 2012, , http://www.genomeweb.com/beyond-gina-states-build-patchwork-protections
42. Massachusetts state legislature. Senate Bill S01080, 187th General court Regular session
43. Vermont state legislature. House Bill 368 2011, 2012 Legislature. Regular session.
44. American Bar Association Resolution 114: ABA Urges Direct Access to Diagnostic Medical Testing. 2011, American Bar Association., http://www.abanow.org/2011/07/2011am114
45. American Medical Association: Gene Patenting. , http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/related-policy-topics/gene-patenting.page
46. NSGC Public Policy Committee Backgrounder on Human Gene Patents. 2010, NSGC Public Policy Committee., http://www.nsgc.org/Portals/0/Position%20Statements/PPC_Patent_Rationale_Final.pdf
47. Holland JJ. Human Gene Patent Decision to be Decided Down by US Supreme Court. Huffington Post 2012, , http://www.huffingtonpost.com/2012/12/02/human-gene-patent_n_2220737.html
48. Critchton M. Patenting life. The New York Times 2007, , http://www.nytimes.com/2007/02/13/opinion/13crichton.html?_r=0
49. Gene tests 'create undue stress'. BBC News 2008, , http://news.bbc.co.uk/2/hi/health/7616073.stm
50. Lewis R. The Battle of Prenatal Tests. Scientific American Blog 2012, , http://blogs.scientificamerican.com/guest-blog/2012/12/05/the-battle-of-the-prenatal-tests
51. Canadian Colition for Genetic Fairness/Coalition canadienne pour l'équité génétique (CCGF/CCEG). , http://www.ccgf-cceg.ca/
52. Gene testing exposes us all to discrimination. Sydney Morning Herald 2010, , http://www.smh.com.au/opinion/editorial/gene-testing-exposes-us-all-to-discrimination-20100215-o2ta.html
53. Heim-Meyers B. Do we need legislation to protect Canadians' genetic rights? The Yes side. Globe and Mail 2012, , http://www.theglobeandmail.com/news/national/time-to-lead/do-we-need-legislation-to-protect-canadians-genetic-rights-the-yes-side/article6188021